论文部分内容阅读
目的研究脑血栓患者运用双嘧达莫和阿司匹林肠溶片联合治疗的临床疗效。方法 100例脑血栓患者,随机分为观察组与对照组,各50例。对照组患者采用阿司匹林肠溶片治疗,观察组采用双嘧达莫和阿司匹林肠溶片联合治疗。观察比较两组患者的临床治疗效果。结果观察组疗效显著高于对照组,不良反应发生率显著低于对照组,差异均有统计学意义(P<0.05)。结论脑血栓患者运用双嘧达莫和阿司匹林肠溶片联合治疗的临床疗效显著,值得广泛推广。
Objective To study the clinical efficacy of dipyridamole combined with aspirin enteric-coated tablets in patients with cerebral thrombosis. Methods 100 patients with cerebral thrombosis were randomly divided into observation group and control group, 50 cases in each group. Patients in the control group were treated with aspirin enteric-coated tablets. The observation group was treated with dipyridamole and aspirin enteric-coated tablets. The clinical effects of two groups were observed and compared. Results The observation group was significantly higher than the control group, the incidence of adverse reactions was significantly lower than the control group, the difference was statistically significant (P <0.05). Conclusion The clinical efficacy of combination therapy with dipyridamole and aspirin enteric-coated tablets in patients with cerebral thrombosis is significant and worthy of widespread promotion.